| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/30/2023 | 469.62% | EF Hutton | → $4.5 | Initiates Coverage On | → Buy |
| 08/16/2023 | 153.16% | Cantor Fitzgerald | $3 → $2 | Maintains | Overweight |
| 06/01/2023 | 659.49% | EF Hutton | → $6 | Assumes | → Buy |
| 03/16/2023 | 659.49% | EF Hutton | → $6 | Reiterates | → Buy |
| 02/01/2023 | — | Benchmark | Downgrades | Buy → Hold | |
| 12/19/2022 | 659.49% | EF Hutton | → $6 | Initiates Coverage On | → Buy |
| 08/23/2022 | 532.91% | Maxim Group | $8 → $5 | Maintains | Buy |
| 08/15/2022 | 659.49% | Aegis Capital | $9 → $6 | Maintains | Buy |
| 11/16/2021 | 1039.24% | Aegis Capital | $10 → $9 | Maintains | Buy |
| 03/10/2021 | 912.66% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 01/25/2021 | 1165.82% | Aegis Capital | $8 → $10 | Maintains | Buy |
| 08/19/2020 | 912.66% | Aegis Capital | $10 → $8 | Maintains | Buy |
| 05/06/2020 | 1165.82% | Aegis Capital | → $10 | Initiates Coverage On | → Buy |
What is the target price for VolitionRX (VNRX)?
The latest price target for VolitionRX (AMEX: VNRX) was reported by EF Hutton on October 30, 2023. The analyst firm set a price target for $4.50 expecting VNRX to rise to within 12 months (a possible 469.62% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX: VNRX) was provided by EF Hutton, and VolitionRX initiated their buy rating.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a initiated with a price target of $0.00 to $4.50. The current price VolitionRX (VNRX) is trading at is $0.79, which is within the analyst's predicted range.